May 2025 in “International Ayurvedic Medical Journal” This review discusses meditation and Suryanamaskar for women with PCOS and reports no new clinical results; the authors emphasize Suryanamaskar's potential benefits and the need for lifestyle modifications.
April 2025 in “International Journal of Homoeopathic Sciences” This case study reported that homeopathic treatment focusing on emotional stress and immune support led to positive outcomes in a patient with alopecia totalis following emotional trauma, suggesting a potential benefit of addressing both physical and emotional factors.
January 2025 in “Journal of Education Health and Sport” In this study, metformin was highlighted as effective in improving metabolic parameters and restoring ovulatory function in women with PCOS by enhancing insulin sensitivity, inhibiting hepatic gluconeogenesis, and influencing lipid metabolism, although a tailored, comprehensive treatment plan remains essential.
January 2025 in “Directory of Open access Books (OAPEN Foundation)” This book reviews the symptoms, diagnosis, and treatments for Polycystic Ovary Syndrome, providing a comprehensive exploration but reports no new clinical results.
January 2025 in “International Journal of Unani and Integrative Medicine” This review explores hirsutism in women with PCOS, analyzing its pathophysiology and management through both modern medicine and Unani perspectives, and suggests combining these approaches for more holistic care, while calling for future research to enhance treatment efficacy and safety.
January 2025 in “JCEM Case Reports” Among postmenopausal women, this case study observed that a rare ovarian tumor called thecoma, found via MRI, was associated with high testosterone levels and symptoms of mild virilization such as hirsutism, indicating surgery as the primary treatment.
January 2025 in “Open Life Sciences” This study observed that transgenic mice with overexpression of HE4 developed keratitis and severe corneal opacity, suggesting that HE4 may significantly influence keratopathy and inflammatory responses in the eye.
January 2025 in “Updates in clinical dermatology” This study highlights that the skin can serve as a marker for systemic health during COVID-19 by showing symptoms like rashes and pigmentary changes, while also emphasizing dermatologists' key role in diagnosing COVID-induced and vaccine-related skin issues to enhance patient care and address vaccine hesitancy.
January 2025 in “International Journal of Forest Animal and Fisheries Research” This review found that while elevated DHEA levels are observed in some women with PCOS, especially those with hyperandrogenism, inconsistencies across studies suggest that standardized measurement and analyses are needed to clarify DHEA's role as a biomarker and factor in PCOS pathophysiology.
January 2025 in “American Journal of Translational Research” This study reported that the combination of EE-CPA and raloxifene effectively manages PCOS-related infertility, enhancing pregnancy outcomes through improvements in metabolism, sex hormones, ovarian function, and endometrial receptivity, without significantly increasing adverse effects.
January 2025 in “Haematology International Journal” This study describes a functional disorder in the ovary, known as stromal hyperplasia, characterized by the proliferation of ovarian stroma and luteinization of stromal cells, which is linked to excessive androgen production and elevated testosterone levels.
December 2024 in “DIET FACTOR (Journal of Nutritional & Food Sciences)” This study reports that fenugreek seed extract (Furocyst®) improved body weight, ovarian cysts, ovary size, hair growth, and menstrual regularity in women with PCOS, indicating its potential as an effective phytotherapeutic option for managing the condition.
December 2024 in “African Journal of Biomedical Research” This review discusses various risk factors and potential therapeutic interventions for PCOS but reports no new clinical results.
December 2024 in “AACE Clinical Case Reports” This study highlights a rare case of ovarian hyperthecosis in a 58-year-old postmenopausal woman, presenting with polycythemia and severe hyperandrogenism symptoms, with resolution of symptoms following laparoscopic bilateral oophorectomy.
December 2024 in “The New Indian Journal of OBGYN” This study, assessing PCOS patients, found a significant positive correlation between increased ovarian volume and elevated insulin resistance, suggesting that larger ovaries may indicate a higher degree of insulin resistance.
November 2024 in “Future Science OA” This case report describes a rare instance of a Leydig cell tumor in a 35-year-old pregnant woman, discovered incidentally during a cesarean section. The tumor typically presents with symptoms of excess androgen, though it can range from asymptomatic to rapid virilization.
October 2024 in “Plastic & Reconstructive Surgery Global Open” This study found that using overexpanded tissue expanders effectively restored the hairy scalp in 25 patients with scalp alopecia, resulting in high satisfaction and minimal complications, emphasizing the importance of careful patient selection and follow-up.
October 2024 in “Journal of the Endocrine Society” This case report details a postmenopausal woman whose hyperandrogenism was attributed to ovarian stromal hyperplasia, ultimately resolved with bilateral salpingo-oophorectomy.
October 2024 in “Journal of the Endocrine Society” In this case report, a 62-year-old woman with hyperandrogenism and polycythemia was diagnosed with a rare ovarian steroid cell tumor, highlighting the importance of considering such tumors in similar presentations; surgical removal led to symptom and lab normalization.
October 2024 in “Journal of the Endocrine Society” This case report describes a patient with an ovarian steroid cell tumor that initially presented as non-classical adrenal hyperplasia, emphasizing the difficulty in differential diagnosis with hyperandrogenism and the importance of close clinical monitoring.
October 2024 in “Journal of the Endocrine Society” This case report highlights the challenge of differentiating between non-classical adrenal hyperplasia and steroid cell tumors of the ovary in a patient presenting with hyperandrogenism.
October 2024 in “Journal of the Endocrine Society” In this case report, the authors describe the diagnosis and management of a rare case of hyperandrogenism in a postmenopausal woman, attributed to coexisting ovarian Leydig cell and Brenner tumors, with improvement in symptoms following bilateral salpingo-oophorectomy.
September 2024 in “AYUSHDHARA” This article examines the Ayurvedic approach to treating polycystic ovarian syndrome with Basti therapy and discusses its potential for both lean and obese phenotypes, but provides no new clinical results.
September 2024 in “Journal of the American Academy of Dermatology” This study found that phenoxyethanol is the most common contact allergen in over-the-counter hair loss products, but its role in the development or exacerbation of frontal fibrosing alopecia remains unclear.
July 2024 in “Journal of Pediatric Endocrinology and Metabolism” This study presents two adolescent cases of ovarian hyperthecosis, a rare cause of severe hyperandrogenism, highlighting management strategies involving gonadotropin suppression and hormone replacement after excluding androgen-producing adrenal and ovarian tumors.
July 2024 in “Journal of the ASEAN Federation of Endocrine Societies” In this case study, a 69-year-old woman with signs of virilization and high testosterone levels was found to have an ovarian steroid cell tumor, highlighting the importance of systematically investigating such symptoms in postmenopausal women to determine the underlying etiology and prevent poor prognosis.
In this case report, a 54-year-old woman with hirsutism was found to have a benign ovarian cystadenofibroma, which resolved after surgery, highlighting the importance of evaluating postmenopausal women for ovarian causes of androgen excess.
May 2024 in “International Seven Multidisciplinary Journal” This study reviewed the literature to explore the dermatological symptoms associated with Polycystic Ovary Syndrome, such as hirsutism and acne, highlighting the importance of a multidisciplinary approach for optimal management of the syndrome, including controlling circulating androgen levels.
May 2024 in “Indian Journal of Pharmacology” In this case report, an 11-year-old girl with alopecia totalis initially treated with minoxidil experienced hypertrichosis, which reversed upon stopping the medication; hair regrowth on the scalp was achieved with tofacitinib after minoxidil discontinuation.
April 2024 in “International Journal of Advanced Research in Science Communication and Technology” This review explores the impact of synthetic and herbal drugs on hormone levels and ovarian tissue in PCOD but reports no new clinical findings.